nivolumab,cabozantinib,ipilimumab
bms,ipsen
['gu ', 'nivolumab', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'renal,(-adrenal)', 'cabopoint', 'advanced i', 'cabo ', 'nivo']
excellent talk by laurence albiges, md &amp; phd she told us that in the interim analysis, cabo demonstrated preliminary efficacy in pts with advanced rcc after progression on cpi-based combination therapy, irrespective of 1l regimen. #ascogu2023 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.